Differential effects of teriparatide and strontium ranelate on bone remodeling and formation in postmenopausal women with osteoporosis.
Phase of Trial: Phase IV
Latest Information Update: 22 May 2014
At a glance
- Drugs Teriparatide (Primary) ; Strontium ranelate
- Indications Osteoporosis
- Focus Pharmacodynamics
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 31 Mar 2006 New trial record.